Latest news
FDA Approves Oveporexton for NT1, Grants RMAT Designation to Sasineprocel in PD, Emerging Literature in Spinal Muscular Atrophy - NeurologyLiveNeurologyLive · Sun, 09 Aug 2026 16:12:15 GMTFDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1 - managedhealthcareexecutive.commanagedhealthcareexecutive.com · Fri, 07 Aug 2026 20:06:51 GMTFDA Approves Oveporexton, First Orexin Receptor Agonist for Narcolepsy Type 1 - Patient Care OnlinePatient Care Online · Fri, 07 Aug 2026 06:16:23 GMTNew Narcolepsy Drug Signals a Shift From Symptom Management to Disease-Based Treatment - Medical DailyMedical Daily · Fri, 07 Aug 2026 01:30:22 GMTFDA approves first drug for full range of narcolepsy symptoms - Medical XpressMedical Xpress · Thu, 06 Aug 2026 22:00:03 GMTFDA Approves First-in-Class Narcolepsy Drug - MedPage TodayMedPage Today · Thu, 06 Aug 2026 20:46:04 GMTFDA Approves Oveporexton for Adults With Narcolepsy Type 1 - HMP Global Learning NetworkHMP Global Learning Network · Thu, 06 Aug 2026 20:00:56 GMTTakeda wins U.S. FDA approval for narcolepsy drug ORZEYFUL - International Business TimesInternational Business Times · Thu, 06 Aug 2026 15:36:29 GMT